PCM
ONC

Penserra Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Penserra Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,981
Closed -$1.01M – 1153
2025
Q3 		$1.01M Buy
2,981
+79
+3% +$24K 0.01% 444
2025
Q2 		$702K Sell
2,902
-6,174
-68% -$1.51M 0.01% 467
2025
Q1 		$2.47M Buy
+9,076
New +$2.12M 0.04% 274

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Penserra Capital Management's ONC Position: Q4 2025 in Review

Penserra Capital Management sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 2,981 shares — an estimated $1.01M sold.

Penserra Capital Management first reported a position in ONC in Q1 2025 and held it in 3 quarters. The position peaked at $2.47M in Q1 2025. 285 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • Penserra Capital Management reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • Penserra Capital Management sold 2,981 BeOne Medicines Ltd shares in Q4 2025, an estimated $1.01M.
  • Penserra Capital Management first reported a position in BeOne Medicines Ltd in Q1 2025 and held it in 3 quarters.
  • Penserra Capital Management's BeOne Medicines Ltd position peaked at $2.47M in Q1 2025.
  • 285 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on Penserra Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.